arrow
T

Toshimitsu Fujii

department of gastroenterology and hepatology
H指数:26
被引数:2,615

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of upadacitinib for Crohn’s disease in patients in East Asia: a post hoc analysis of randomized phase 3 studies

东亚太区克罗恩病患者中使用乌帕替尼的疗效与安全性:基于随机III期研究的回顾性分析

2026-08-300
OA
Disease Behaviour Progression and Associated Factors in Crohn's Disease Patients: the Nationwide Inception Cohort Study of Crohn's Disease (iCREST-CD)

克罗恩病患者疾病行为进展及其相关因素:克罗恩病全国起始队列研究(iCREST-CD)

2026-01-010
PRE
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease

在基线使用皮质类固醇的中度至重度活动性克罗恩病患者中,乌帕替尼的疗效与安全性。

2025-11-011
OAAI
Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study
2025-11-010
OAAI
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a post hoc analysis of safety and effectiveness in older (≥ 65 years) and younger (<65 years) patients

日本溃疡性结肠炎患者中托法替布上市后监测:一项针对老年(≥65岁)和年轻(<65岁)患者安全性与有效性的事后分析

2025-11-010
PRE
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study

溃疡性结肠炎患者中≥70岁与<70岁患者接受维多利珠单抗治疗的实际有效性与安全性:多中心回顾性研究

2025-05-150
OA
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data

日本溃疡性结肠炎患者中托法替尼上市后监测:安全性及有效性数据的最终报告

2025-04-210
OA
Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn's disease activity in the small bowel

血清富含亮氨酸的α-2糖蛋白对小肠克罗恩病活动的诊断准确性和截断值

2025-02-140
OA
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study

影响维多珠单抗治疗溃疡性结肠炎1年持续性的因素: 一项多中心、回顾性真实世界研究

2025-01-160
OA
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study (DEC, 10.1007/s00535-024-02176-x, 2024)
2024-12-270
OAAI
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study

抗整合素αvβ6抗体作为诊断溃疡性结肠炎的生物标志物:一项全国多中心验证研究

2024-11-281
OA